MedPath

Effect of psycho-educational intervention on hot flushes and related symptoms after treatment for localised breast cancer

Conditions
Hot flushes in women with previous localised breast cancer
Cancer - Breast
Registration Number
ACTRN12606000186550
Lead Sponsor
Supportive Care Research Group at the Peter MacCallum Cancer Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
25
Inclusion Criteria

Localised breast cancer (Stage I, II & III); Adjuvant therapy (surgery ± chemotherapy ± radiotherapy) completed for more than 3 months but no more than 5 years (may take tamoxifen or aromatase inhibitor but no modification allowed during the time of the study); Have HF (³ 5 / 24 hours).

Exclusion Criteria

Women taking pharmacological medications for HF; Women with severe depression who are currently seeing a psychiatrist or taking antidepressants for < 3 months; Women currently undergoing cognitive-behavioural therapy; Women cognitively impaired.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of hot flushes measured with a hot flushes diary where each hot flush and its severity will be recorded for 7 days at each timepoint.[Measured twice before the intervention (at 4 weeks apart) and twice after the intervention (at the end of the intervention and 3 months after). ];Daily hot flush score (frequency x severity score for each HF) measured with a hot flushes diary where each hot flush and its severity will be recorded for 7 days at each timepoint.[Measured twice before the intervention (at 4 weeks apart) and twice after the intervention (at the end of the intervention and 3 months after). ]
Secondary Outcome Measures
NameTimeMethod
Changes in interference of hot flushes with different aspects of life[Measured twice before the intervention (at 4 weeks apart) and twice after the intervention (at the end of the intervention and 3 months after).];Changes in sleep, fatigue, anxiety and mood disturbance[Measured twice before the intervention (at 4 weeks apart) and twice after the intervention (at the end of the intervention and 3 months after).]
© Copyright 2025. All Rights Reserved by MedPath